Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative ...

Despite recent market turbulence, Oppenheimer Asset Management expressed continued optimism about equities. Learn more here.

My grandfather J. Robert Oppenheimer shared the first principle of nuclear weapons: The only safety from them is in ...

As interest rates fall, business development companies', or BDCs, return on equity will likely be pressured. Oppenheimer ...

A popular theory frequently utilized by technical analysts suggests U.S. stocks could be headed for one last leg higher over ...

Meeting to be held on April 3-4 hosted by Oppenheimer. Published first on TheFly – the ultimate source for real-time, market-moving breaking ...

Christopher Nolan’s Oppenheimer was that rare movie that was both a box office hit and a serious award winner. It also had ...

The state's banking commissioner said the married founders of Valuex Research and Valuex Fintech used investor money for rent ...

In a report released today, Matthew Biegler from Oppenheimer reiterated a Buy rating on Biomea Fusion (BMEA – Research Report), with a price ...

Joshua Oppenheimer made his name directing two disturbing documentaries, The Act of Killing (2012) and The Look of Silence ...

Oppenheimer was rightly lauded for his only two previous features, hybrid documentaries The Act of Killing (regularly in ...